Back to search

North Dakota State University

Identification of Aptamer Specific for Carcinoembryonic Antigen and its Analytical Applications

Abstract

dc:description.abstract

Carcinoembryonic Antigen (CEA) is an approved cancer biomarker by the Food and Drug Administration (FDA) for the early detection, diagnosis, and for the use in the regular screening of patients at high risk for the development of cancer. Traditional methods to determine the concentrations of CEA are based on utilizing antibodies. In this project, a graphene oxide (GO)–assisted systematic evolution of ligands through exponential enrichment (SELEX) was used to identify DNA aptamers specific for CEA. The dissociation constants of the identified aptamers were determined with surface plasmon resonance (SPR). Comparison of the dissociation constants of aptamers isolated from the GO-based SELEX and affinity SELEX found the dissociation constant of the aptamers isolated from GO-assisted SELEX was three times lower than aptamers isolated from the affinity SELEX. The analytical applications of the identified aptamers were studied by developing a colorimetric test for the determination of CEA with un-modified gold nanoparticles.

Degree

thesis:*
Grantor dc:publisher
North Dakota State University
Year dc:date.issued
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lund, Michelle
ORCID dc:identifier.orcid

Rights

dc:rights
Statement dc:rights
  • NDSU Policy 190.6.2

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/10365/28604

Chain of custody

source
Harvested from
North Dakota State University
Base URL
library.ndsu.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Lund, Michelle. Identification of Aptamer Specific for Carcinoembryonic Antigen and its Analytical Applications. North Dakota State University, 2017. https://hdl.handle.net/10365/28604